Gruppo Farmaimpresa’s ready-to-market products: the PJPharma line We present an overview of some of the products in our ready-to-market PJPHARMA line; remember that they can be made, also, in private label. Each is carefully designed to provide effective and safe solutions for wellness and health. We are excited to introduce our line to future distributors,…
MDR extension: accepted proposal to amend European Regulation 2017/745 (MDR) The proposal to amend European Regulation 2017/745 MDR and European Regulation 2017/746 IVDR, announced on December 9 during the EPSCO meeting, has been approved. The main objective of European Regulation 2017/745 MDR (Medical Device Regulation) is to “establish a robust, transparent, predictable and sustainable regulatory…
Gruppo FarmaImpresa is among the first Italian companies to obtain MDR certifications for some of its substance-based medical devices As a reminder, the new Regulation (EU) 2017/745 or MDR (Medical Device Regulation) is the European medical device regulation that defines regulations and constraints that all manufacturers and distributors must comply with in order to place…